Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Meeting report: Validation of toxicogenomics-based test systems: ECVAM-ICCVAM/NICEATM considerations for regulatory use.

Corvi R, Ahr HJ, Albertini S, Blakey DH, Clerici L, Coecke S, Douglas GR, Gribaldo L, Groten JP, Haase B, Hamernik K, Hartung T, Inoue T, Indans I, Maurici D, Orphanides G, Rembges D, Sansone SA, Snape JR, Toda E, Tong W, van Delft JH, Weis B, Schechtman LM.

Environ Health Perspect. 2006 Mar;114(3):420-9.

5.

Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).

Kinsner-Ovaskainen A, Maxwell G, Kreysa J, Barroso J, Adriaens E, Alépée N, Berg N, Bremer S, Coecke S, Comenges JZ, Corvi R, Casati S, Dal Negro G, Marrec-Fairley M, Griesinger C, Halder M, Heisler E, Hirmann D, Kleensang A, Kopp-Schneider A, Lapenna S, Munn S, Prieto P, Schechtman L, Schultz T, Vidal JM, Worth A, Zuang V.

Altern Lab Anim. 2012 Jul;40(3):175-81.

PMID:
22943518
6.

Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.

Spielmann H, Liebsch M.

Toxicol In Vitro. 2001 Aug-Oct;15(4-5):585-90. Review.

PMID:
11566595
7.

The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.

Ceridono M, Tellner P, Bauer D, Barroso J, Alépée N, Corvi R, De Smedt A, Fellows MD, Gibbs NK, Heisler E, Jacobs A, Jirova D, Jones D, Kandárová H, Kasper P, Akunda JK, Krul C, Learn D, Liebsch M, Lynch AM, Muster W, Nakamura K, Nash JF, Pfannenbecker U, Phillips G, Robles C, Rogiers V, Van De Water F, Liminga UW, Vohr HW, Wattrelos O, Woods J, Zuang V, Kreysa J, Wilcox P.

Regul Toxicol Pharmacol. 2012 Aug;63(3):480-8. doi: 10.1016/j.yrtph.2012.06.001. Epub 2012 Jun 9.

PMID:
22687423
8.

Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies.

Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A.

Environ Health Perspect. 2007 Jun;115(6):924-31. Epub 2007 Feb 6.

9.

[Validation and regulatory acceptance of alternative methods for toxicity evaluation].

Ohno Y.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2004;(122):1-9. Review. Japanese.

PMID:
15940895
10.

ECVAM-ICCVAM: prospects for future collaboration.

Schechtman LM, Stokes WS.

Altern Lab Anim. 2002 Dec;30 Suppl 2:227-36. Review.

PMID:
12513682
11.

The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop.

Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, Pallardy M, Pieters R, Reid L, Tryphonas H, Tschirhart E, Tuschl H, Vandebriel R, Gribaldo L.

J Immunotoxicol. 2005 Apr 1;2(2):61-83. doi: 10.1080/15476910590965832.

PMID:
18958661
12.

Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities-Report from an ECVAM workshop.

Pfuhler S, Kirkland D, Kasper P, Hayashi M, Vanparys P, Carmichael P, Dertinger S, Eastmond D, Elhajouji A, Krul C, Rothfuss A, Schoening G, Smith A, Speit G, Thomas C, van Benthem J, Corvi R.

Mutat Res. 2009 Nov-Dec;680(1-2):31-42. doi: 10.1016/j.mrgentox.2009.09.002. Epub 2009 Sep 16.

PMID:
19765670
13.

The FDA's regulatory role in the ICCVAM process.

Schechtman LM, Stokes WS.

Altern Lab Anim. 2004 Jun;32 Suppl 1B:663-8.

PMID:
23581155
14.

Future improvements: replacement in vitro methods.

Balls M.

ILAR J. 2002;43 Suppl:S69-73. Review.

PMID:
12388855
16.
17.
18.
19.

Meeting report: alternatives for developmental neurotoxicity testing.

Lein P, Locke P, Goldberg A.

Environ Health Perspect. 2007 May;115(5):764-8. Epub 2007 Jan 29.

Supplemental Content

Support Center